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Modeling the relationship between chemical structure and molecular activity is a key task
in drug development and precision medicine. In this paper, we utilize a novel deep learning
architecture to jointly train coordinated embeddings of chemical structures and transcrip-
tional signatures. We do so by training neural networks in a coordinated manner such that
learned chemical representations correlate most highly with the encodings of the transcrip-
tional patterns they induce. We then test this approach by using held-out gene expression
signatures as queries into embedding space to recover their corresponding compounds. We
evaluate these embeddings’ utility for small molecule prioritization on this new benchmark
task. Our method outperforms a series of baselines, successfully generalizing to unseen
transcriptional experiments, but still struggles to generalize to entirely unseen chemical
structures.
Keywords: Small Molecule Prioritization, Gene Expression, Deep Learning, Information
Retrieval
1. Introduction
Identifying molecules that are likely to have a specific biological effect is a cornerstone of drug
discovery and a key component of efforts to achieve precision medicine.
Classically, computational prioritization of small molecules for new indications has centered
on predicting molecular affinities for specific biological targets. To this end, computational
chemistry has developed a rich toolkit of methods, ranging from biophysics-driven techniques
such as molecular docking1 to more recent advances in machine-learning that enable allow
end-to-end learning of predictive models from raw molecular graphs.2,3 Additional methods
leverage the literature or curated knowledge graphs to annotate molecules.4 Structure-driven
approaches to drug development are promising, in part, because they can be applied to novel
compounds in order to prioritize testing with more expensive assays. A limitation of this
paradigm when it comes to approaching new diseases, however, is that it generally assumes
a priori knowledge of specific targets that one hopes to manipulate in order to achieve thera-
peutic effect.
More recently, connectivity mapping has emerged as a complementary approach to drug
development.5 In connectivity mapping, compounds are foremost characterized not by spe-
cific targets or chemical properties, but by the broad transcriptional effects they induce in
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cells. Organizations such as the Broad Institute and the Library of Integrated Network-based
Cellular Signatures (LINCS) Consortium have enabled the production of public datasets6,7 of
more than a million experiments, in which gene expression is measured in cells that have been
treated with various molecular (and genetic) perturbations. Fueled by this data, researchers
have sought to compute purely functional descriptions of small molecules’ effects, and use
these signatures to try to match drugs in an unbiased manner to new indications and even
to specific patients.8–14 Connectivity mapping is promising, in part because it can be used
to discover new indications of drugs while requiring very minimal assumptions about their
mechanism of action. However, current approaches to connectivity mapping are generally lim-
ited to small molecules whose perturbational effects have been directly measured using gene
expression assays or whose transcriptional signatures can be inferred from other experiments
as by Hodos et al.15
In this paper, we attempt to merge these two paradigms by learning aligned embeddings
of chemical structure and perturbational signatures (See Figure 1). We do so by training
neural networks in a coordinated manner such that learned chemical representations correlate
most highly with the encodings of the transcriptional patterns they induce. We then test this
approach by using held out gene expression signatures as queries into the embedding space
and recover their corresponding compounds.
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Fig. 1. Overview of our coordinated representation learning method. Neural networks are jointly
trained to embed gene expression profiles and small molecule structures such that transcriptional
signatures are brought into close proximity with their corresponding perturbagens. Given a cross-
modal alignment, gene expression signatures can then be used as queries to rank chemical structures
by their likelihood to induce such a signature.
If successful, this approach may combine some of the positive elements of structure-driven
and connectivity-driven approaches to compound prioritization: like connectivity mapping, it
can be used to rank drugs from transcriptional signatures in a target-free manner. And like
classic QSAR methods, once the chemical encoder is trained, it can in principle be applied to
existing compound libraries in silico to nominate molecules to be run through more expensive
assays. The results of our experiments demonstrate that this paradigm shows promise, but
that the task of generalizing to new compounds proves particularly challenging.
2. Background: Multi-View Representation Alignment and Deep
Embedding Learning
Multi-view representation learning seeks to learn representations that relate information from
multiple views of the same data, such as an image of a scene and a text description of that same
scene. In multi-view representation alignment, embeddings of each data modality are learned
separately but in a coordinated manner, such that different views of the same scene are induced
to be similar per some metric. In multi-view representation fusion, data from different views of
the same scene are integrated into a single, more compact and potentially richer representation.
In this work, we attempt to learn aligned representations of gene expression perturbational
signatures and small molecules’ structures, such that gene expressions are embedded in close
proximity to the small molecules that induced them.
Multi-view representation alignment can be achieved through a variety of methods, includ-
ing distance-based, similarity-based, and correlation-based alignment. One classic method for
representation alignment, which we leverage as a baseline in this paper, is canonical correla-
tion analysis (CCA).16 CCA takes a pair of datasets X = [x1 . . . xn] and Y = [y1 . . . ym] and
seeks to identify vectors a ∈ Rn and b ∈ Rm such that
(a′, b′) = argmax corra,b(a
TX, bTY )
The resultant random variables U = aTX and V = bTY are the first pair of canonical
variables. This process can be iteratively repeated up to minm, n, times with the restriction
that each subsequent pair of canonical variables are uncorrelated with the previous pairs.
Taken together, the procedure produces a linear mapping from the datasets X and Y that
maximizes the element-wise correlation between the embeddings of paired rows from the two
datasets.
A wide range of additional methods for multi-modal alignment have been proposed
since CCA, including methods to align embeddings using distance-based, similarity-based,
correlation-based, and ranking-based penalties during training.17
Ranking-based methods for multi-view representation alignment, such as that described
by Deng at al,18 allow the incorporation of ranking information into the training procedure,
which may be important in tasks such as gene expression where perturbation signals may
be small relative to baseline state. In addition, the field of rank-based embedding learning is
intertwined with a broader literature of uni-modal embedding learning, which pioneered such
architectures as Siamese19,20 and Triplet networks.21 These networks optimize embeddings to
bring similar data together while driving dissimilar data apart. An analysis of best practices
working with this architecture can be found in Wu et al.22
3. Methods
3.1. Dataset Preparation
3.1.1. Data Acquisition and Subsetting
All raw data in this study comes from the Next-Generation Connectivity Map (CMap)
provided by the LINCS Consortium and the NIH.7 Analyses were conducted using the
so-called ”Level 3” L1000 data as described in Subramanian et al (available for down-
load at https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE70138 and https:
//www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92742). The raw data comes in the
form of gene expression profiles generated using the L1000 technology, a low-cost assay which
measures 978 ”landmark” genes that have been deemed representative of the full transcrip-
tome. The CMAP contains data from a variety of chemical and genetic perturbations applied
to a range of human cell lines, along with several control samples per plate treated with buffer.
In order to eliminate as many sources of variance as possible beyond drug structure and cel-
lular response, we limited our analysis to experiments conducted on the PC3 cell line and
incubated with small molecules for 24 hours at a dose of 10µm. For drug structures, we used
the SMILES23 structures provided by LINCS, which we canonicalized to a consistent format
using RDKIT.24
Data was partitioned 80-10-10 into training, validation, and test sets by experimental plate
ID. A fixed random seed was chosen prior to any modeling that would maximize the number
of unseen chemical structures represented in the validation and test sets. The test set was
untouched until the final evaluation of models selected based on performance in the validation
set. Breakdown of the splits is in Table 1 of the Appendix.
3.1.2. Preprocessing and Feature Engineering
Gene expression intensity values from the training, validation, and test sets were centered
and scaled at the gene-level based on the mean and standard deviation of each gene intensity
across the training set. For each gene expression profile representing a chemical perturbation,
we then computed four core sets of features to power our baselines and deep representations:
the post-perturbational gene expression itself, corresponding gene expression intensities from
a control signature on the same plate, the log2 fold-change between the perturbation and
control signatures, and the difference between these gene expression signatures.
For our initial baseline implementations of Canonical Correlation Analysis, we pre-
computed features for each drug based on classical and state-of-the-art numerical representa-
tions of small molecules. For the former, we used extended-connectivity fingerprints as imple-
mented in RDKit, a standard representation used in many computational chemistry applica-
tions.25 For more modern features, we used the deep representations described in Yang et al,
which achieved state-of-the-art performance in predicting 128 biophysical properties from the
PubChem Bioassasy database.2,26
3.2. Canonical Correlation Analysis
Canonical Correlation Analysis was performed using the CCA function implemented in SciKit
Learn.27 CCA models were fit in all cases using only the data in the training set, and then
used to transform the gene expression and chemical structures in the test set.
Default settings from SciKit Learn’s CCA function were used, with two exceptions: first,
the number of components was set to 50. The number 50 was chosen because a preliminary
benchmark ranging from 5-125 components showed that 50 components had mildly superior
performance in retrieval tasks on the validation set. Second, the maximum number of iterations
were increased to 1000, since some initial experiments failed to converge at the default setting
of 500.
3.3. Deep Coordinated Representation Learning Algorithm
We designed a cross-model ranking algorithm to learn representations of chemical structure
and gene expression that would each be jointly optimized to facilitate small molecule retrieval
from gene expression signatures.
An overview of this algorithm is depicted in Figure 1. In brief, gene expression profiles and
drug structures are each embedded through separate neural networks into a shared embedding
space. These networks are optimized together to produce representations that minimize the
distance in embedding space between gene expression signatures and the drugs that induced
them, while maximizing the distance between transcriptional signatures and the embeddings
of other structures. Below we describe the components of this network and its training in more
detail.
3.3.1. Gene Expression and Drug Embedding
Gene expressions are embedded using self-normalizing neural networks, which are feedforward
neural networks that employ the SeLU activation function.28 The depth and shape of the
hidden layers was left, in principle, as a hyperparameter, though in practice we generally
found two hidden units of size 1024 and 512 between the input and embedding layers to
give adequate performance. In addition, we employed AlphaDropout for regularization on the
hidden layers, the exact value of which was left as a hyperparameter but generally set to
0.1. No activation function or dropout was used before the final embedding layer. A natural
source of data augmentation was employed by randomly sampling only one control signature
on each iteration of the algorithm, which meant that every epoch saw a slightly different
featurization of every sample. A histogram of the number of controls per plate can be found
in the Appendix.
Chemical structures were embedded using a message-passing neural network passed into
a feedforward neural network. The message-passing network was initialized using the same
message-passing network from Yang et al described above and used as a baseline feature set
for CCA. The MPN was then allowed to be fine-tuned in tandem with the feedforward layers.
The number of hidden layers was a hyperparameter usually set to one, and the embedding
layer was of identical architecture to the embedding layer of the gene expression encoder.
For all of our reported experiments, gene expressions and drug structures were embedded
into a 128 dimensional space.
3.3.2. Loss Functions and Sampling Scheme
We developed customized margin-based triplet and quadruplet losses for our task. As described
in Wu et al,22 an an adaptive margin loss for embedding learning can be defined over two data
points i and j as
lmargin := (α+ yi,j(Dij − β))+
, where D is distance function (here euclidean distance), α defines a permissible margin
of separation, β controls the boundary between positive and negative pairs, and yi,j is an
indicator variable equal to 1 if i and j are of the same class and 0 otherwise.
Given this margin loss, we first explored cross-modal triplet networks18,21 to align gene
expression embeddings to molecular structure embeddings. In these networks, we provide the
loss function with an anchor embedding of one modality and with one positive (matching)
and one negative (non-matching) embedding of the other modality. We then define the triplet
loss as the sum of the margin losses between (a) the anchor and the positive embedding,
and (b) and the anchor and the negative embedding. The network is thus optimized to bring
the positive embedding within the margin of the anchor and negative embedding outside the
margin. To give an example: if the anchor is a drug structure, the positive example is a gene
expression signature that was induced by that drug structure, and the negative example is a
gene expression signature induced by some other molecular structure. The loss function then
tries to force the gene expression and its corresponding small molecule structure toward each
other in embedding space and away from the other drug embedding. Throughout this paper, we
refer to our triplet networks as ”‘Gene Expression-First” if their anchor embeddings are gene
expressions and their positive/negative embeddings are drug structures, and as “Chemical
Structure-First” otherwise.
We also explored a quadruplet design that combined the so-called “Gene expression-First“
and ”Chemical Structure-First” losses. In the quadruplet architecture, we sample a gene ex-
pression signature as anchor, positive and negative small molecule structures, and an addi-
tional gene expression signature induced by the negative small molecule structure. We then
compute both the “Gene expression-first” triplet margin loss using the anchor gene expression
signature and two moleculur structures, as well as the “Chemical structure-first” margin loss
using the first structure embedding as an anchor and the two gene expression embeddings
as positive and negative examples. These two margin-based triplet losses are then summed
together to form the quadruplet margin loss.
For sampling, we adapted the distance-weighted sampling scheme described in Wu et al,
which was successful with their margin-based approach.22 Since our goal is to learn to rank
across modalities, we precomputed the average distance in gene expression space between every
pair of small molecule structures in the dataset. This was performed by computing the average
of the post-perturbational signatures induced by each small molecule and computing their
pairwise correlations. These pairwise correlations were then used to guide distance-weighted
uniform sampling between among potential negative perturbagens.
3.3.3. Training and Hyperparameter Selection
Each model was trained on a single Nvidia GeForce GTX 1080 GPU for a maximum of 100
epochs. Early stopping was used to select the model with the best mean reciprocal rank on
the validation set. Training was conducted using the Adam optimizer29 with a learning rate
of 3e−4. Hyperparameters that we manually explored included the depth of the feedforward
neural networks (ranging from 0-3 hidden layers), the dropout rate (ranging 0-0.2), activation
functions (sigmoid vs vs ReLU vs SeLU), and transforming gene expressions intensities to
ranks. This limited manual hyperparameter search identified the values described above which
we used in all experiments.
3.4. Experiments
We evaluated our coordinated representation learning strategy using an information-retrieval
task. Specifically, for each perturbational gene expression profile in the test set, we rank
all small molecules based on their correlation to that pertrubation in the induced, aligned
embedding space. We then use the standard information retrieval metrics median rank (MR),
mean reciprocal rank (MRR), and Hits or Recall @ K to score the quality of the embeddings
for retrieval purposes.30 In addition, we plot the empirical cumulative distribution function
of the ranks of the true perturbagen among the results. This is equivalent to a continuous-
valued Hits @ K for all possible K in this dataset, and allows for a visual comparison between
experiments.
Successful coordinated representation learning requires both learning rich representations
of GE and chemical data, as well as the aligning them to each other. To test these separately
and together, the above evaluations were repeated in the following ablation studies:
Featurization. Embeddings were systematically replaced with various alternative ap-
proaches to featurization. Chemical structures were replaced with Morgan Fingerprints and
a state-of-the-art message passing neural network optimized for biophysical activity, which
happens to be the same architecture used in the molecule embedder in our network. Gene
expression embeddings were replaced in the ablation study as raw log2 fold changes to make
it computational tractable.
Loss Function for Deep Model Results are reported for both triplet margin training
strategies as well as for the training strategy without quadruplet margin loss function.
Alignment For all ablation studies in which non-learned features were used, CCA was
applied as described above in order to align the features as best as linearly possible. In addition,
we ran the evaluation on the coordinated embeddings with and without post-processing with
CCA to test how complete the alignment process had been.
Test Set All above evaluations were run twice: First on the entire test set, to evaluate
the method’s ability to generalize to unseen gene expression signatures on new plates. Second,
we evaluated generalization to exclusively unseen molecules, by computing retrieval scoring
specifically on the subset of the test set whose perturbagens were not present in the training
set.
3.5. Source Code
The source code developed for us in this project is freely available on Github at https:
//github.com/sgfin/molecule_ge_coordinated_embeddings.
4. Results
Results are reported in Figure 2, Table 1, and Appendix Figure 2. We summarize here:
Featurization Deep coordinated embeddings of perturbational signatures and small
molecules – both individually and in concert – improved retrieval performance on all met-
rics.
Loss Function for Deep Model The model trained with the quadruplet margin loss
function outperformed both triplet margin training strategies.
Alignment Post-processing the coordinate embeddings appeared to slightly improve per-
formance on all models, though the improvement was smaller for the quadruplet model.
Test Set Restricting the test set to previously unseen compounds caused a marked drop in
performance of all models, though the relative performance of models was generally consistent.
Fig. 2. Empirical CDF representing the Recall @ K for all possible K in the dataset. As can be seen
in panel A, deep encodings improve recall over all other feature types. In panel B, the same general
trends appear to hold, but performance is markedly worse for all methods. ECDF for Triplet-based
models is found in the Appendix.
5. Discussion
5.1. Observations
In this paper, we have sought to present both a new biomedical machine learning task –
cross-modal retrieval of molecular structure from perturbational signatures – as well as a set
of approaches to benchmark future work on this task.
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Our results indicate that the task appears feasible, and that the richer models afforded by
recent advances in deep learning show marked improvements over baseline methods.
Nevertheless, generalization to unseen molecular libraries – arguably the greatest promise
of this method over pure connectivity mapping approaches – seems to be very challenging.
It is interesting to note, however, that while performance on the unseen molecule set was
poor, the most expressive models still had the highest performance; this seems to indicate
that increased model capacity rather than merely better regularization will be necessary to
generalize to these molecules.
We are intrigued by the observation that our quadruplet loss appeared to perform better
than either triplet loss in terms of retrieval performance on the test sets. In addition, we
note that while CCA seemed to improve the alignment of embeddings in every model, the
embeddings trained with the quadruplet loss changed very little with CCA, to the point that
the eCDF curves almost perfectly overlay each other.
5.2. Limitations and Future Work
From the perspective of task formulation, one area of future interest is the development of
custom metrics to score model ranks. As it stands, the evaluation strategy counts the exact
perturbagen as correct, and all other small molecules as equally incorrect. This will potentially
under-estimate model performance, as it ignores the possibility of other plausible candidates.
It would therefore be useful to consider metrics that incorporates functional or structural
similarity to provide non-zero scores to reasonable alternatives. An additional concern is that
the evaluation on unseen molecular structures is limited to only 300 molecules, which means
that those scores will likely have higher bias and variance. Finally, expanding the task to
include – and ideally translate between – perturbational signatures from multiple cell types
and dosages will be essential to assessing and optimizing generalizability to new biological
settings.
From the perspective of model formulation, there are several follow-up experiments that we
are excited to pursue that would require only additional computational and human resources.
These include a more dedicated hyperparameter optimization search and the implementation
of test-time augmentation by ensembling predictions over repeat control sampling. In addition,
we would like to compute confidence intervals for all experimental values computed by boot-
strapping. Such exercises will be indispensable in identifying which if any of the comparisons
in performance may be due to statistical aberration rather than substantive difference.
Slightly more sophisticated follow-up work includes the investigation of more intelligent
pretraining strategies and negative sampling techniques, which may prove essential for im-
proved generalization. In addition, as described in Li et al, there are a wide variety of addi-
tional architectures that could be tried for this task, such as Cross-Modal Factor Analysis,
Kernel CCA, and a range of novel deep learning architectures.17 Anecdotally, one model which
we did begin to explore was Deep Canonical Correlation Analysis,31 which on first implemen-
tation has not produced useful embeddings for this task. These results were not included
formally in this work, however, due to insufficient time to ensure the results weren’t due to
poor hyperparameters.
Of greatest interest to us as authors is a deep examination of the failure modes that take
place when the model tries to generalize to unseen molecules. In particular, we would like to
characterize what precisely are the properties of chemical libraries that do or do not enable
mutual generalizability. It is our hope that elucidating these pitfalls could lead both to better
algorithms and to better chemical libraries.
6. Conclusion
We present a method for jointly modeling chemical structure and corresponding transcriptional
perturbations, using deep coordinated representation learning. The method shows promise on
a benchmark task of unseen gene expression signatures, but fails to adequately generalize
to entirely unseen chemical structures. Future directions to overcome this generalization gap
could yield interesting fruit for both chemical biology and library design.
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Appendix
Table 2. Details of train-validation-test splits.
Split # Gene Expression Signatures # Distinct Molecules # Molecules not in Train
Train 29,548 6318 N/A
Validation 2642 2248 307
Test 3370 3370 312
Fig. 3. Histogram showing the number of controls per plate.
AB
Fig. 4. Empirical CDF comparing triplet-based models to the quadruplet-based model. Represents
the Recall @ K for all possible K in the dataset.
